| Literature DB >> 30767180 |
Handan Wand1, Natashia Morris2, Reshmi Dassaye3, Tarylee Reddy2, Gita Ramjee2.
Abstract
South Africa has the highest burden of human immunodeficiency virus (HIV) infections in the world. There is also growing evidence that an individual's risk of contracting HIV is increased by the presence of other sexually transmitted infections (STIs). The primary objective of this study was to examine the association between the prevalence of STIs in a cohort of South African women who enrolled in HIV prevention trials (2002-2012). The current study linked the individual factors with the community-level characteristics using geo-referencing. These multi-level data were analyzed in generalized additive mixed models settings. In the multivariate logistic regression model, younger age (odds ratio [OR] 4.30, 95% CI 3.20, 5.77 and OR 2.72, 95% CI 2.02, 3.66 for age < 25 and 25-29, respectively); being single/not cohabiting (OR 4.57, 95% CI 3.18, 6.53), two + sex partners (OR 1.46, 95% CI 1.18,1.80); parity < 2 (OR 2.04, 95% CI 1.53, 2.72), parity = 2 (OR 1.85, 95% CI 1.37, 2.48), and using injectables (contraceptive) (OR 1.53, 95% CI 1.13, 2.06) were all significantly associated with increased prevalence of STIs. Women who resided in the communities with high proportions of female headed-households were also significantly at higher risk for STIs (OR 1.20, p = .0025). Because these factors may reflect characteristics of the larger groups who share similar cultural norms and social environments, they can provide considerable insight into the spread of STIs. Prevention strategies based on individual and community-level drivers of STIs are likely to be the most effective means of targeting and reaching those at greatest risk of infection. This strategy has the potential to play a significant role in the epidemic's trajectory.Entities:
Keywords: Generalized additive models; Individual-level and population-level risk factors; Sexually transmitted infection
Mesh:
Year: 2019 PMID: 30767180 PMCID: PMC6944771 DOI: 10.1007/s10508-018-1315-3
Source DB: PubMed Journal: Arch Sex Behav ISSN: 0004-0002
Community and individual-level measurements collected
other factors considered but not included in the current analysis are: average distance to a hospital; average distance to a clinic; % population without pipe/running water; % households (HH) with no electricity; %HH traditional informal living;
condom used in last sex;
Age standardized;
past 3 months
Figure 1aSmooth function of % female population 18–25 for STI diagnosis
Figure 1b:Smooth function of % adults single/not-cohabiting for STI diagnosis
Figure 1c:Smooth function of % female headed households for STI diagnosis
Figure 1d:Smooth function of age standardized HIV incidence rate for STI diagnosis:
Figure 1e:Smooth function of % population unemployed for STI diagnosis:
Figure 1f:Smooth function of % Population no education for STI diagnosis
Community-level factors:
Analysing Community level characteristics using logistic regression and generalized additive models.
| per 1% increase | 8.351 | <0.001 | 0.14 (0.05,0.39) | |
| <8% | 1 (reference) | |||
| 8%+ | 1.25 (1.08, 1.45) | 0.003 | ||
| per 1% increase | 8.935 | <0.001 | 0.25 (0.16, 38.4) | |
Note: other population level factors considered but did not show any associations with the STIs were: average distance to a hospital : median: 6.5 km, IQR: 4.1–13.6); average distance to a clinic:
median: 1.5 km, IQR: 8.8, 19.0); % population without pipe/running water median: 20.8%, IQR: 12%, 40%); % percent households (HH) with no electricity: median:3%, IQR: 2%, 4%; %HH traditional informal living: median:32.8%, IQR: 23.%, 54.7%.
Correlates of STI (chlamydia, gonorrhoea or syphilis) diagnosis: individual and community level factors
| Individual-level | % | Adjusted Odds Ratio [ | p-value |
|---|---|---|---|
| <25 years | 45 | 4.30 (3.20, 5.77) | <0.001 |
| 25–29 years | 21 | 2.72 (2.02, 3.66) | <0.001 |
| 30+ years | 34 | 1 | |
| No | 25 | 1 | |
| Yes | 18 | 1.36 (1.11, 1.67) | 0.004 |
| Don’t know | 57 | 1.91 (1.49, 2.44) | <0.001 |
| Yes | 14 | 1 | |
| No | 86 | 4.57 (3.18, 6.53) | <0.001 |
| <2 | 87 | 1 | |
| 2+ | 13 | 1.46 (1.18, 1.80) | <0.001 |
| 0/1 child | 45 | 2.04 (1.53, 2.72) | <0.001 |
| 2 children | 23 | 1.85 (1.37, 2.48) | <0.001 |
| 3+ children | 22 | 1 | |
| No contraceptive | 14 | 1 | |
| Injectables | 51 | 1.53 (1.13, 2.06) | <0.001 |
| Oral contraceptive | 10 | 1.02 (0.69, 1.47) | 0.982 |
| Others | 25 | 1.07 (0.75, 1.54) | 0.694 |
| <50% | 43 | 1 | |
| 50%+ | 57 | 1.26 (1.08, 1.45) | 0.002 |
| <40% | 26 | 1 | |
| 40%+ | 74 | 1.17 (1.02, 1.38) | 0.025 |
results were further adjusted for individual trials;
male/female condoms, IUD;
intra-class
coefficient (ICC) = 19.56%